The feasibility of monitoring NF-κB associated cytokines: TNF-α, IL-1α, IL-6, and IL-8 in whole saliva for the malignant transformation of oral lichen planus

Molecular Carcinogenesis

Volumn 44, Issue 2, 2005, Pages 77-82

  Rhodus, Nelson L ^a,c   Cheng, Bin ^b   Myers, Sandra ^c   Miller, Lindsay ^d   Ho, Vu ^d   Ondrey, Frank ^d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Malignant transformation; NF kappaB dependent cytokines; Oral lichen planus; Whole unstimulated saliva

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARCINOGENESIS; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIAGNOSTIC VALUE; DYSPLASIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOSTIMULATION; IN VIVO STUDY; LICHEN PLANUS; MALE; MALIGNANT TRANSFORMATION; MOUTH CARCINOMA; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; SALIVA ANALYSIS; SMOKING; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

CELL TRANSFORMATION, NEOPLASTIC; CYTOKINES; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; LICHEN PLANUS, ORAL; MOUTH NEOPLASMS; NF-KAPPA B; PILOT PROJECTS; SALIVA; SMOKING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 25844472378     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.20113     Document Type: Article

References (56)

1. Pindborg JJ, Reichart PA, Smith CJ, van der Waal I. World Health Organization International Histological Classification of Tumor: Histological typing of cancer and precancer of the oral mucosa. The 2nd edition. Berlin: Springer; 1997.
2. Mattsson U, Jontell M, Holmstrup P. Oral lichen planus and malignant transformation: Is a recall of patients justified? Crit Rev Oral Biol Med 2002;13:390-396.
3. Silverman S, Jr. Oral lichen planus: A potentially premalignant lesion. J Oral Maxillofac Surg 2000;58:1286-1288.
4. Eisenberg E. Oral lichen planus: A benign lesion. J Oral Maxillofac Surg 2000;58:1278-1285.
5. Rode M, Kogoj-Rode M. Malignant potential of the reticular form of oral lichen planus over a 25-year observation period in 55 patients from Slovenia. J Oral Sci 2002;44:109-111.
6. Brown RS, Bottomley WK, Puente E, Lavigne GJ. A retrospective evaluation of 193 patients with oral lichen planus. J Oral Pathol Med 1993;22:69-72.
7. Lanfranchi-Tizeira HE, Aguas SC, Sano SM. Malignant transformation of atypical oral lichen planus: A review of 32 cases. Med Oral 2003;8:2-9.
8. Rodstrom PO, Jontell M, Mattsson U, Holmberg E. Cancer and oral lichen planus in a Swedish population. Oral Oncol 2004;40:131-138.
9. Gandolfo S, Richiardi L, Carrozzo M, et al. Risk of oral squamous cell carcinoma in 402 patients with oral lichen planus: A follow-up study in an Italian population. Oral Oncol 2004;40:77-83.
10. O'Flatharta C, Leader M, Kay E, et al. Telomerase activity detected in oral lichen planus by RNA in situ hybridisation: not a marker for malignant transformation. J Clin Pathol 2002;55:602-607.
11. Ogmundsdottir HM, Hilmarsdottir H, Astvaldsdottir A, Johannsson JH, Holbrook WP. Oral lichen planus has a high rate of TP53 mutations. A study of oral mucosa in Iceland. Eur J Oral Sci 2002;110:192-198.
12. Valente G, Pagano M, Carrozzo M, et al. Sequential immunohistochemical p53 expression in biopsies of oral lichen planus undergoing malignant evolution. J Oral Pathol Med 2001;30:135-140.
13. Sniezek JC, Matheny KE, Burkey BB, Netterville JL, Pietenpol JA. Expression of p63 and 14-3-3s in normal and hyperdifferentiated mucosa of the upper aerodigestive tract. Otolaryngol Head Neck Surg 2002;126:598-601.
14. Nylander K, Coates PJ, Hall PA. Characterization of the expression pattern of p63 alpha and delta Np63 alpha in benign and malignant oral epithelial lesions. Int J Cancer 2000;87:368-372.
15. Zhang L, Cheng X, Li Y, et al. High frequency of allelic loss in dysplastic lichenoid lesions. Lab Invest 2000;80:233-237.
16. Zhang L, Michelsen C, Cheng X, Zeng T, Priddy R, Rosin MP. Molecular analysis of oral lichen planus: A malignant lesion? Am J Pathol 1997;151:323-327.
17. Garcia-Pola Vallejo MJ, Anitua Roldan MJ, Fernandez Alvarez BE, Garcia Martin JM, Lopez-Muniz A. Study comparative of Ki-67 expression in oral lichen planus and oral leukoplakia. Quantitative analysis. Med Oral 2001;6:364-370.
18. Kim J, Yook JI, Lee EH, et al. Evaluation of premalignant potential in oral lichen planus using interphase cytogenetics. J Oral Pathol Med 2001;30:65-72.
19. Mignogna MD, Fedele S, Lo Russo L, Lo Muzio L, Bucci E. Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: is there any evidence? Oral Oncol 2004;40:120-130.
20. Chen F, Castranova V, Shi X. New insights into the role of nuclear factor-kappaB in cell growth regulation. Am J Pathol 2001;159:3873-3897.
21. Bours V, Bonizzi G, Bentires-Alj M, et al. NF-kappaB activation in response to toxical and therapeutical agents: Role in inflammation and cancer treatment. Toxicology 2000;153:27-38.
22. Nakayama H, Ikebe T, Beppu M, Shirasuna K. High expression levels of nuclear factor kappaB, IkappaB kinase alpha and Akt kinase in squamous cell carcinoma of the oral cavity. Cancer 2001;92:3037-3044.
23. Tamatani T, Azuma M, Aota K, Yamashita T, Bando T, Sato M. Enhanced IkappaB kinase activity is responsible for the augmented activity of NF-kappaB in human head and neck carcinoma cells. Cancer Lett 2001;171:165-172.
24. Yamamoto T, Kimura T, Ueta E, Tatemoto Y, Osaki T. Characteristic cytokine generation patterns in cancer cells and infiltrating lymphocytes in oral squamous cell carcinomas and the influence of chemoradiation combined with immunotherapy on these patterns. Oncology 2003;64:407-415.
25. Nakano Y, Kobayashi W, Sugai S, Kimura H, Yagihashi S. Expression of tumor necrosis factor-alpha and interleukin-6 in oral squamous cell carcinoma. Jpn J Cancer Res 1999; 90:858-866.
26. Woods KV, El-Naggar A, Clayman GL, Grimm EA. Variable expression of cytokines in human head and neck squamous cell carcinoma cell lines and consistent expression in surgical specimens. Cancer Res 1998;58:3132-3141.
27. Jablonska E, Piotrowski L, Grabowska Z. Serum levels of IL-1b, IL-6, TNF-a, sTNF-RI and CRP in patients with oral cavity cancer. Pathol Oncol Res 1997;3:126-129.
28. Wang YF, Chang SY, Tai SK, Li WY, Wang LS. Clinical significance of interleukin-6 and interleukin-6 receptor expressions in oral squamous cell carcinoma. Head Neck 2002;24:850-858.
29. Gallo O, Gori AM, Attanasio M, et al. Interleukin-6 and acute-phase proteins in head and neck cancer. Eur Arch Otorhinolaryngol 1995;252:159-162.
30. Lalla RV, Spiro JD, Tanzer ML, Kreutzer DL. Association of fibrin and interleukin 8 in human oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;95:452-457.
31. Watanabe H, Iwase M, Ohashi M, Nagumo M. Role of interleukin-8 secreted from human oral squamous cell carcinoma cell lines. Oral Oncol 2002;38:670-679.
32. Santoro A, Majorana A, Bardellini E, Festa S, Sapelli P, Facchetti F. NF-kappaB expression in oral and cutaneous lichen planus. J Pathol 2003;201:466-472.
33. Khan A, Farah CS, Savage NW, Walsh LJ, Harbrow DJ, Sugerman PB. Th1 cytokines in oral lichen planus. J Oral Pathol Med 2003;32:77-83.
34. Sun A, Chia JS, Chang YF, Chiang CP. Serum interleukin-6 level is a useful marker in evaluating therapeutic effects of levamisole and Chinese medicinal herbs on patients with oral lichen planus. J Oral Pathol Med 2002;31:196-203.
35. Yamamoto T, Osaki T. Characteristic cytokines generated by keratinocytes and mononuclear infiltrates in oral lichen planus. J Invest Dermatol 1995;104:784-788.
36. Rhodus NL, Cheng B, Myers S, Bowles W, Ho V, Ondrey F. A comparison of the pro-inflammatory NFkappa B dependent cytokines: TNF-alpha, IL-1 alpha, IL-6 and IL-8 in different oral fluids from oral lichen planus patients. J Clin Immunol 2005; 278-283.
37. Bryan RT, Nicholls JH, Harrison RF, Jankowski JA, Wallace DM. The role of beta-catenin signaling in the malignant potential of cystitis glandularis. J Urol 2003;170:1892-1896.
38. Knight B, Yeoh GC, Husk KL, et al. Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J Exp Med 2000;192:1809-1818.
39. Song SY, Gannon M, Washington MK, et al. Expansion of Pdx1-expressing pancreatic epithelium and islet neogenesis in transgenic mice overexpressing transforming growth factor alpha. Gastroenterology 1999;117:1416-1426.
40. Fox JG, Wang TC, Rogers AB, et al. Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia. Gastroenterology 2003;124:1879-1890.
41. Behbakht K, Friedman J, Heimler I, Aroutcheva A, Simoes J, Faro S. Role of the vaginal microbiological ecosystem and cytokine profile in the promotion of cervical dysplasia: A case-control study. Infect Dis Obstet Gynecol 2002;10:181-186.
42. Dvorakova K, Payne CM, Ramsey L, et al. Increased expression and secretion of interleukin-6 in patients with Barrett's esophagus. Clin Cancer Res 2004;10:2020-2028.
43. Hobisch A, Rogatsch H, Hittmair A, et al. Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue. J Pathol 2000;191:239-244.
44. Ellmerich S, Scholler M, Duranton B, et al. Promotion of intestinal carcinogenesis by Streptococcus bovis. Carcinogenesis 2000;21:753-756.
45. Hu DE, Hori Y, Fan TP. Interleukin-8 stimulates angiogenesis in rats. Inflammation 1993;17:135-143.
46. Coxon A, Bolon B, Estrada J, et al. Inhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritis. Arthritis Rheum 2002;46:2604-2612.
47. Mota F, Calder V, Rutault K, Singer A, Chain B. Characterization of soluble factors from cultures of premalignant cervical epithelium. Eur J Gynaecol Oncol 1999;20:262-267.
48. Mota F, Rayment N, Chong S, Singer A, Chain B. The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium. Clin Exp Immunol 1999;116:33-40.
49. Johnson GK, Poore TK, Squier CA, Wertz PW, Reinhardt RA, Vincent SD. Prostaglandin E2 and interleukin-1 levels in smokeless tobacco-induced oral mucosal lesions. J Periodontal Res 1994;29:430-438.
50. Giannopoulou C, Cappuyns I, Mombell, A. Effect of smoking on gingival crevicular fluid cytokine profile during experimental gingivitis. J Clin Periodontol 2003;30:996-1002.
51. Eppel W, Worda C, Frigo P, Manavi M, Czerwenka K. The influence of cotinine on interleukin 6 expression in smokers with cervical preneoplasia. Acta Obstet Gynecol Scand 2000; 79:1105-1111.
52. Dranoff G. Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 2004;4:11-22
53. Krause I, Valesini G, Scrivo R, Shoenfeld Y. Autoimmune aspects of cytokine and anticytokine therapies. Am J Med 2003;115:390-397.
54. Krutchkoff DJ, Eisenberg E. Lichenoid dysplasia: A distinct histopathologic entity. Oral Surg Oral Med Oral Pathol 1985;60:308-315.
55. Navazesh M. Methods for collecting saliva. Ann NY Acad Sci 1993;694:72-77.
56. Ondrey FG, Dong G, Sunwoo J, et al. Constitutive activation of transcription factors NF-(kappa)B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines. Mol Carcinog 1999;26:119-129.